William E. Klunk
Impact in
- Psychiatry and Mental health top 0.01%
- Dementia and Cognitive Impairment Research
- Physiology top 0.01%
- Alzheimer's disease research and treatments
Papers in
-
- Dementia and Cognitive Impairment Research 160
- Physiology 145
- Alzheimer's disease research and treatments 142
- Co-authors
- Chester A. Mathis (183 shared papers)John C. Morris (10 shared papers)Bradley T. Hyman (16 shared papers)Steven T. DeKosky (79 shared papers)David S. Knopman (3 shared papers)Clifford R. Jack (2 shared papers)Martin N. Rossor (3 shared papers)Walter J. Koroshetz (2 shared papers)
- Journals
- Alzheimer s & Dementia (70 papers)Neurobiology of Aging (35 papers)Neurology (20 papers)Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (13 papers)NeuroImage (10 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
William E. Klunk
345 papers receiving 45.5k citations
William E. Klunk's Hit Papers
Peers
Comparison fields: 5 of 193
- Psychiatry and Mental health 19.3k
- Physiology 19.7k
- Neurology 4.9k
- Biological Psychiatry 1.0k
- Cognitive Neuroscience 7.8k
Countries citing papers authored by William E. Klunk
This map shows the geographic impact of William E. Klunk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Klunk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Klunk more than expected).
Fields of papers citing papers by William E. Klunk
This network shows the impact of papers produced by William E. Klunk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Klunk. The network helps show where William E. Klunk may publish in the future.
Co-authors
The 25 scholars most cited alongside William E. Klunk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 354 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Hit paper breakdown → | 2011 | 14354 |
| 2 | Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory Hit paper breakdown → | 2005 | 1717 |
| 3 | Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans Hit paper breakdown → | 2005 | 1001 |
| 4 | [ 11 C]PIB in a nondemented population Hit paper breakdown → | 2006 | 874 |
| 5 | Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents Hit paper breakdown → | 2003 | 871 |
| 6 | Imaging β-amyloid burden in aging and dementia Hit paper breakdown → | 2007 | 864 |
| 7 | Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly Hit paper breakdown → | 2008 | 850 |
| 8 | 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Hit paper breakdown → | 2008 | 790 |
| 9 | The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET Hit paper breakdown → | 2014 | 755 |
| 10 | Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease Hit paper breakdown → | 2008 | 727 |
| 11 | Brain Imaging in Alzheimer Disease Hit paper breakdown → | 2012 | 684 |
| 12 | Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease Hit paper breakdown → | 2011 | 669 |
| 13 | -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease Hit paper breakdown → | 2007 | 654 |
| 14 | Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease Hit paper breakdown → | 2009 | 649 |
| 15 | 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study Hit paper breakdown → | 2010 | 573 |
| 16 | Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B Hit paper breakdown → | 2005 | 562 |
| 17 | Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. Hit paper breakdown → | 1989 | 550 |
| 18 | Validating novel tau positron emission tomography tracer Hit paper breakdown → | 2015 | 471 |
| 19 | Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. | 2005 | 466 |
| 20 | 2008 | 422 |
About William E. Klunk
William E. Klunk is a scholar working on Psychiatry and Mental health, Physiology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Cognitive Neuroscience, having authored 354 papers that have together received 46.7k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (160 papers), Alzheimer's disease research and treatments (142 papers), Functional Brain Connectivity Studies (40 papers), Down syndrome and intellectual disability research (37 papers), Medical Imaging Techniques and Applications (30 papers), Advanced Neuroimaging Techniques and Applications (23 papers), Computational Drug Discovery Methods (20 papers) and Neuroscience and Neuropharmacology Research (16 papers). The work is most often cited by research in Psychiatry and Mental health (19.3k citations), Physiology (19.7k citations), Neurology (4.9k citations), Biological Psychiatry (1.0k citations) and Cognitive Neuroscience (7.8k citations). William E. Klunk has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Chester A. Mathis, John C. Morris, Bradley T. Hyman, Steven T. DeKosky, David S. Knopman, Clifford R. Jack, Martin N. Rossor, Walter J. Koroshetz, Jennifer J. Manly and Richard C. Mohs. Their work appears in journals such as Alzheimer s & Dementia, Neurobiology of Aging, Neurology, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring and NeuroImage.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.